Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions
14
2.2.1 Drug delivery devices 14
2.2.1.1 Needle-free Injections
14
2.2.1.2 Inhalation Systems 14
2.2.1.3 Infusion Systems 15
3
Healthcare Sector Review 16
3.1 Healthcare Expenditure 16
3.2
Healthcare Infrastructure 19
3.3 Healthcare Policy 21
3.3.1 Health
Insurance Act 22
3.3.2 Healthcare Allowance Act 22
3.3.3 The
Exceptional Medical Expenses Act 22
4 Drug Delivery Devices in Netherlands
23
4.1 Drug Delivery Devices Overall Revenues (2000-2012) 23
4.2 Drug
Delivery Devices Overall Volume (2000-2012) 29
4.3 Drug Delivery Devices
Company Shares (2005-2006) 32
5 Inhalation Systems in Netherlands 33
5.1 Inhalation Systems Overall Revenues (2000-2012) 33
5.1.1 Metered Dose
Inhaler Devices Overall Revenues (2000-2012) 37
5.1.2 Dry Powder Inhaler
Devices Overall Revenues (2000-2012) 39
5.2 Inhalation Systems Overall
Volume (2000-2012) 41
5.2.1 Metered Dose Inhaler Devices Overall Volume
(2000-2012) 43
5.2.2 Dry Powder Inhaler Devices Overall Volume (2000-2012)
45
5.3 Inhalation Systems Average Price (2000-2012) 47
5.3.1 Metered
Dose Inhaler Devices Average Price (2000-2012) 47
5.3.2 Dry Powder Inhaler
Devices Average Price (2000-2012) 49
5.4 Inhalation Systems Distribution
Share (2005-2006) 51
5.5 Inhalation Systems Company Share (2005-2006)
52
6 Infusion Systems in Netherlands 53
6.1 Infusion Systems Overall
Revenues (2000-2012) 53
6.1.1 Infusion Disposable Sets Overall Revenue
(2000-2012) 57
6.1.2 Syringe Pumps Overall Revenue (2000-2012) 59
6.1.3 Infusion Pumps Overall Revenues (2000-2012) 61
6.2 Infusion Systems
Overall Volume (2000-2012) 63
6.2.1 Infusion Disposable Sets Overall
Volume (2000-2012) 64
6.2.2 Syringe Pumps Overall Volume (2000-2012)
66
6.2.3 Infusion Pumps Overall Volume (2000-2012) 68
6.3 Infusion
Systems Average Price (2000-2012) 70
6.3.1 Infusion Pumps Average Price
(2000-2012) 70
6.3.2 Syringe Pumps Average Price (2000-2012) 72
6.3.3
Infusion Disposable Sets Average Price (2000-2012) 74
6.4 Infusion Systems
Distribution Share (2005-2006) 76
6.5 Infusion Systems Company Share
(2005-2006) 77
7 AstraZeneca PLC Company Profile 78
7.1 Company
Overview 78
7.2 Business Overview 78
7.2.1 Products 79
7.2.2
History 80
7.3 Locations And Subsidiaries 81
8 3M Company Profile
83
8.1 Company Overview 83
8.2 Business Overview 83
8.2.1 Consumer
and Office 83
8.2.1.1 Overview 83
8.2.1.2 Capital Expenditure 83
8.2.1.3 Market View 83
8.2.1.4 Key Strategies 83
8.2.2 Display and
Graphics 84
8.2.2.1 Overview 84
8.2.2.2 Financials 84
8.2.2.3
Capital Expenditure 84
8.2.2.4 Market View 84
8.2.2.5 Key Strategies
84
8.2.3 Electro and Communications 84
8.2.3.1 Overview 84
8.2.3.2
Financials 84
8.2.3.3 Capital Expenditure 84
8.2.3.4 Market View
85
8.2.3.5 Key Strategies 85
8.2.4 Health Care 85
8.2.4.1 Overview
85
8.2.4.2 Financials 85
8.2.4.3 Capital Expenditure 85
8.2.4.4
Market View 85
8.2.4.5 Key Strategies 86
8.2.5 Industrial and
Transportation 86
8.2.5.1 Overview 86
8.2.5.2 Financials 86
8.2.5.3 Capital Expenditure 86
8.2.5.4 Market View 86
8.2.5.5 Key
Strategies 86
8.2.6 Safety, Security and Protection Services 86
8.2.6.1 Overview 86
8.2.6.2 Financials 87
8.2.6.3 Capital Expenditure
87
8.2.6.4 Market View 87
8.2.6.5 Key Strategies 87
8.2.7 Products
87
8.3 Value Chain Analysis 89
8.3.1 Manufacturing 89
8.3.1.1 In
House Manufacturing 89
8.3.2 Product Development 89
8.3.2.1 Regulatory
Approvals 89
8.3.2.2 Clinical Trials 90
8.3.2.3 Research and
Development 90
8.3.3 Sales and Marketing 90
8.3.3.1 Partnerships and
Alliances 90
8.3.3.2 Licensing Agreements 90
8.3.3.3 E-distribution
90
8.4 SWOT Analysis 91
8.4.1 3M Company Strengths 91
8.4.1.1
Strong performance of Industrial and Transportation segment 91
8.4.1.2
Focused research and development 91
8.4.1.3 Decentralized operations
92
3M Company Weaknesses 92
8.4.1.4 Increased operating costs in the
U.S. 92
8.4.1.5 Personal care segment' s poor performance 92
3M Company
Opportunities 92
8.4.1.6 Expanding global presence 92
8.4.1.7 The
liquid crystal display 92
8.4.1.8 Enhancing brand portfolio 93
3M
Company Threats 93
8.4.1.9 Foreign currency fluctuations 93
8.4.1.10
Increasing cost of raw materials 93
8.4.1.11 Trend for private labels
93
8.5 Revenue Analysis 93
8.5.1 Revenue by Segment 93
8.5.2
Revenue by Geography 94
8.6 Financial and Operational Review 96
8.6.1
Financial Statements 96
8.6.2 Financial Ratios 97
8.7 Locations And
Subsidiaries 98
9 Baxter International Company Profile 99
9.1 Company
Overview 99
9.2 Business Overview 99
9.2.1 BioScience 99
9.2.1.1
Overview 99
9.2.1.2 Financials 99
9.2.1.3 Capital Expenditure 99
9.2.2 Medication Delivery 99
9.2.2.1 Overview 99
9.2.2.2 Financials
100
9.2.2.3 Capital Expenditure 100
9.2.3 Renal 100
9.2.3.1
Overview 100
9.2.3.2 Financials 100
9.2.3.3 Capital Expenditure
100
9.2.4 Products 100
9.2.5 History 101
9.3 Value Chain Analysis
103
9.3.1 Manufacturing 104
9.3.1.1 In House Manufacturing 104
9.3.2 Product Development 104
9.3.2.1 Regulatory Approvals 104
9.3.2.2
Clinical Trials 104
9.3.2.3 Research and Development 104
9.3.3 Sales
and Marketing 105
9.3.3.1 Partnerships and Alliances 105
9.4 SWOT
Analysis 105
9.4.1 Baxter International Inc. Strengths 106
9.4.1.1
Diversified geographic presence 106
9.4.1.2 Sturdy research and
development activities 106
9.4.1.3 Strong financial performance 106
9.4.2 Baxter International Inc. Weaknesses 106
9.4.2.1 High levels of
inventory 106
9.4.2.2 Decline in revenues of medication delivery 106
9.4.2.3 Reduced capital expenditure 107
9.4.3 Baxter International Inc.
Opportunities 107
9.4.3.1 Co-developing alliances 107
9.4.3.2
Increasing End Stage Renal Disease patients 107
9.4.3.3 FDA approval
107
9.4.4 Baxter International Inc. Threats 107
9.4.4.1 Legal
proceedings 107
9.4.4.2 Patent litigation 108
9.4.4.3 Stringent
regulations 108
9.5 Revenue Analysis 108
9.5.1 Revenue by Segment
108
9.5.2 Revenue by Geography 109
9.6 Financial and Operational
Review 110
9.6.1 Financial Statements 110
9.6.2 Financial Ratios
111
9.7 Locations And Subsidiaries 112
9.8 Baxter International Inc.
Pipeline Products 113
9.8.1 Next-Generation Home Hemodialysis Machine
113
9.8.1.1 Product Overview 113
9.8.1.2 Product Description 113
9.8.1.3 Product Status 114
9.8.1.4 Product Milestone 114
10
GlaxoSmithKline plc Company Profile 115
10.1 Company Overview 115
10.2
Business Overview 115
10.2.1 Products 116
10.2.2 History 116
10.3
Locations And Subsidiaries 118
11 Novartis AG Company Profile 121
11.1
Company Overview 121
11.2 Business Overview 121
11.2.1 Major Products
and Services 121
11.3 Locations And Subsidiaries 122
12 Regulation
System 124
12.1 Medical Equipment Approval Process 124
12.1.1
Classification of Medical Devices 125
12.1.2 Conformity Assessment Process
134
12.1.2.1 Class I devices 134
12.1.2.2 Class IIa devices 135
12.1.2.3 Class IIb devices 136
12.1.2.4 Class III devices 137
12.2
Post Market Surveillance (PMS) 137
13 Pricing and Reimbursement 138
13.1 Pricing and Reimbursement in Netherlands 138
14 Distribution
Structure 139
14.1 Distribution Structure in Netherlands 139
15
Appendix 140
15.1 Global Markets Direct Research Methodology 140
15.2
Coverage 141
15.3 Secondary Research 141
15.4 Primary Research 142
15.5 Models 142
15.6 Forecasts 143
15.7 Expert Panels 143
15.8
Currency Conversion 144
15.9 Contact Us 145
15.10 Disclaimer 145
1.1 List of Tables
Table 1: Doctors by Specialty in Netherlands,
2000-2006 20
Table 2: Hospital Wards by Type in Netherlands, 2000-2006
21
Table 3: Drug Delivery Devices, Netherlands, Overall Revenues ($ mn),
2000-2012 23
Table 4: Drug Delivery Devices, Netherlands, Overall Revenues
($ mn), Historic, 2000-2007 24
Table 5: Drug Delivery Devices,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 25
Table 6: Drug
Delivery Devices, Netherlands, Category Revenues ($ mn), 2000-2012 26
Table 7: Drug Delivery Devices, Netherlands, Category Revenues ($ mn),
Historic, 2000-2007 27
Table 8: Drug Delivery Devices, Netherlands,
Category Revenues ($ mn), Forecast, 2007-2012 28
Table 9: Drug Delivery
Devices, Netherlands, Category Volume (Units), 2000-2012 29
Table 10: Drug
Delivery Devices, Netherlands, Category Volume (Units), Historic, 2000-2007
30
Table 11: Drug Delivery Devices, Netherlands, Category Volume (Units),
Forecast, 2007-2012 31
Table 12: Drug Delivery Devices, Netherlands,
Company Share by Revenue ($ mn), 2005-2006 32
Table 13: Inhalation
Systems, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 33
Table 14: Inhalation Systems, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 34
Table 15: Inhalation Systems, Netherlands, Revenue by Segment
($ mn), Historic, 2000-2007 35
Table 16: Inhalation Systems, Netherlands,
Revenue by Segment ($ mn), Forecast, 2007-2012 36
Table 17: Metered Dose
Inhaler Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
37
Table 18: Metered Dose Inhaler Devices, Netherlands, Overall Revenues
($ mn), Forecast, 2007-2012 38
Table 19: Dry Powder Inhaler Devices,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 39
Table 20: Dry
Powder Inhaler Devices, Netherlands, Overall Revenues ($ mn), Forecast,
2007-2012 40
Table 21: Inhalation Systems, Netherlands, Overall Volume
(Units), Historic, 2000-2007 41
Table 22: Inhalation Systems, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 42
Table 23: Metered Dose
Inhaler Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
43
Table 24: Metered Dose Inhaler Devices, Netherlands, Overall Volume
(Units), Forecast, 2007-2012 44
Table 25: Dry Powder Inhaler Devices,
Netherlands, Overall Volume (Units), Historic, 2000-2007 45
Table 26: Dry
Powder Inhaler Devices, Netherlands, Overall Volume (Units), Forecast,
2007-2012 46
Table 27: Metered Dose Inhaler Devices, Netherlands, Average
Price ($), Historic, 2000-2007 47
Table 28: Metered Dose Inhaler Devices,
Netherlands, Average Price ($), Forecast, 2007-2012 48
Table 29: Dry
Powder Inhaler Devices, Netherlands, Average Price ($), Historic, 2000-2007
49
Table 30: Dry Powder Inhaler Devices, Netherlands, Average Price ($),
Forecast, 2007-2012 50
Table 31: Inhalation Systems, Netherlands,
Distribution Share by Revenue ($ mn), 2005-2006 51
Table 32: Inhalation
Systems, Netherlands, Company Share by Revenue ($ mn), 2005-2006 52
Table
33: Infusion Systems, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 53
Table 34: Infusion Systems, Netherlands, Overall Revenues ($
mn), Forecast, 2007-2012 54
Table 35: Infusion Systems, Netherlands,
Revenue by Segment ($ mn), Historic, 2000-2007 55
Table 36: Infusion
Systems, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012 56
Table 37: Infusion Disposable Sets, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 57
Table 38: Infusion Disposable Sets, Netherlands,
Overall Revenues ($ mn), Forecast, 2007-2012 58
Table 39: Syringe Pumps,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 59
Table 40:
Syringe Pumps, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
60
Table 41: Infusion Pumps, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 61
Table 42: Infusion Pumps, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 62
Table 43: Infusion Systems,
Netherlands, Overall Volume (Units), Historic, 2000-2007 63
Table 44:
Infusion Systems, Netherlands, Overall Volume (Units), Forecast, 2007-2012
63
Table 45: Infusion Disposable Sets, Netherlands, Overall Volume
(Units), Historic, 2000-2007 64
Table 46: Infusion Disposable Sets,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 65
Table 47:
Syringe Pumps, Netherlands, Overall Volume (Units), Historic, 2000-2007 66
Table 48: Syringe Pumps, Netherlands, Overall Volume (Units), Forecast,
2007-2012 67
Table 49: Infusion Pumps, Netherlands, Overall Volume
(Units), Historic, 2000-2007 68
Table 50: Infusion Pumps, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 69
Table 51: Infusion Pumps,
Netherlands, Average Price ($), Historic, 2000-2007 70
Table 52: Infusion
Pumps, Netherlands, Average Price ($), Forecast, 2007-2012 71
Table 53:
Syringe Pumps, Netherlands, Average Price ($), Historic, 2000-2007 72
Table 54: Syringe Pumps, Netherlands, Average Price ($), Forecast, 2007-2012
73
Table 55: Infusion Disposable Sets, Netherlands, Average Price ($),
Historic, 2000-2007 74
Table 56: Infusion Disposable Sets, Netherlands,
Average Price ($), Forecast, 2007-2012 75
Table 57: Infusion Systems,
Netherlands, Distribution Share by Revenue ($ mn), 2005-2006 76
Table 58:
Infusion Systems, Netherlands, Company Share by Revenue ($ mn), 2005-2006
77
Table 59: AstraZeneca PLC, Subsidiaries 81
Table 60:
AstraZeneca PLC, Subsidiaries(Contd..) 82
Table 61: 3M Company, SWOT
Analysis, 2006 91
Table 62: 3M Company, Revenue by Segment, USD
Million, 2003-2007 94
Table 63: 3M Company, Revenue by Geography, USD
Million, 2003-2007 95
Table 64: 3M Company, Financial Statements, USD
Million, 2003-2007 96
Table 65: 3M Company, Financial Ratios, USD
Million, 2003-2007 97
Table 66: 3M Company, Subsidiaries 98
Table
67: Baxter International Inc., SWOT Analysis, 2006 105
Table 68:
Baxter International Inc., Revenue by Segment, USD Million, 2003-2007 108
Table 69: Baxter International Inc., Revenue by Geography, USD Million,
2003-2007 109
Table 70: Baxter International Inc., Financial
Statements, USD Million, 2003-2007 110
Table 71: Baxter International
Inc., Financial Ratios, USD Million, 2003-2007 111
Table 72: Baxter
International Inc., Other Locations 112
Table 73: Baxter
International Inc., Subsidiaries 113
Table 74: GlaxoSmithKline plc,
Subsidiaries 119
Table 75: GlaxoSmithKline plc, Subsidiaries(Contd..)
120
Table 76: Novartis Medical Nutrition, Other Locations 122
Table 77: Novartis Medical Nutrition, Other Locations(contd..) 123
Table 78: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 144
1.2 List of Figures
Figure 1: Total Healthcare
Expenditure in Netherlands, 2000 - 2006 17
Figure 2: Healthcare Financing
Framework in Netherlands, 2005 18
Figure 3: Drug Delivery Devices,
Netherlands, Overall Revenues ($ mn), 2000-2012 23
Figure 4: Drug Delivery
Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 24
Figure 5: Drug Delivery Devices, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 25
Figure 6: Drug Delivery Devices, Netherlands,
Category Revenues ($ mn), 2000-2012 26
Figure 7: Drug Delivery Devices,
Netherlands, Category Revenues ($ mn), Historic, 2000-2007 27
Figure 8:
Drug Delivery Devices, Netherlands, Category Revenues ($ mn), Forecast,
2007-2012 28
Figure 9: Drug Delivery Devices, Netherlands, Category Volume
(Units), 2000-2012 29
Figure 10: Drug Delivery Devices, Netherlands,
Category Volume (Units), Historic, 2000-2007 30
Figure 11: Drug Delivery
Devices, Netherlands, Category Volume (Units), Forecast, 2007-2012 31
Figure 12: Drug Delivery Devices, Netherlands, Company Share (%), 2006 32
Figure 13: Inhalation Systems, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 33
Figure 14: Inhalation Systems, Netherlands, Overall Revenues
($ mn), Forecast, 2007-2012 34
Figure 15: Inhalation Systems, Netherlands,
Revenue by Segment ($ mn), Historic, 2000-2007 35
Figure 16: Inhalation
Systems, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012 36
Figure 17: Metered Dose Inhaler Devices, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 37
Figure 18: Metered Dose Inhaler Devices,
Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 38
Figure 19:
Dry Powder Inhaler Devices, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 39
Figure 20: Dry Powder Inhaler Devices, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 40
Figure 21: Inhalation Systems,
Netherlands, Overall Volume (Units), Historic, 2000-2007 41
Figure 22:
Inhalation Systems, Netherlands, Overall Volume (Units), Forecast, 2007-2012
42
Figure 23: Metered Dose Inhaler Devices, Netherlands, Overall Volume
(Units), Historic, 2000-2007 43
Figure 24: Metered Dose Inhaler Devices,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 44
Figure 25: Dry
Powder Inhaler Devices, Netherlands, Overall Volume (Units), Historic,
2000-2007 45
Figure 26: Dry Powder Inhaler Devices, Netherlands, Overall
Volume (Units), Forecast, 2007-2012 46
Figure 27: Metered Dose Inhaler
Devices, Netherlands, Average Price ($), Historic, 2000-2007 47
Figure 28:
Metered Dose Inhaler Devices, Netherlands, Average Price ($), Forecast,
2007-2012 48
Figure 29: Dry Powder Inhaler Devices, Netherlands, Average
Price ($), Historic, 2000-2007 49
Figure 30: Dry Powder Inhaler Devices,
Netherlands, Average Price ($), Forecast, 2007-2012 50
Figure 31:
Inhalation Systems, Netherlands, Distribution Share (%), 2006 51
Figure
32: Inhalation Systems, Netherlands, Company Share (%), 2006 52
Figure 33:
Infusion Systems, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
53
Figure 34: Infusion Systems, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 54
Figure 35: Infusion Systems, Netherlands, Revenue
by Segment ($ mn), Historic, 2000-2007 55
Figure 36: Infusion Systems,
Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012 56
Figure 37:
Infusion Disposable Sets, Netherlands, Overall Revenues ($ mn), Historic,
2000-2007 57
Figure 38: Infusion Disposable Sets, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 58
Figure 39: Syringe Pumps,
Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 59
Figure 40:
Syringe Pumps, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
60
Figure 41: Infusion Pumps, Netherlands, Overall Revenues ($ mn),
Historic, 2000-2007 61
Figure 42: Infusion Pumps, Netherlands, Overall
Revenues ($ mn), Forecast, 2007-2012 62
Figure 43: Infusion Disposable
Sets, Netherlands, Overall Volume (Units), Historic, 2000-2007 64
Figure
44: Infusion Disposable Sets, Netherlands, Overall Volume (Units), Forecast,
2007-2012 65
Figure 45: Syringe Pumps, Netherlands, Overall Volume
(Units), Historic, 2000-2007 66
Figure 46: Syringe Pumps, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 67
Figure 47: Infusion Pumps,
Netherlands, Overall Volume (Units), Historic, 2000-2007 68
Figure 48:
Infusion Pumps, Netherlands, Overall Volume (Units), Forecast, 2007-2012
69
Figure 49: Infusion Pumps, Netherlands, Average Price ($), Historic,
2000-2007 70
Figure 50: Infusion Pumps, Netherlands, Average Price ($),
Forecast, 2007-2012 71
Figure 51: Syringe Pumps, Netherlands, Average
Price ($), Historic, 2000-2007 72
Figure 52: Syringe Pumps, Netherlands,
Average Price ($), Forecast, 2007-2012 73
Figure 53: Infusion Disposable
Sets, Netherlands, Average Price ($), Historic, 2000-2007 74
Figure 54:
Infusion Disposable Sets, Netherlands, Average Price ($), Forecast, 2007-2012
75
Figure 55: Infusion Systems, Netherlands, Distribution Share (%), 2006
76
Figure 56: Infusion Systems, Netherlands, Company Share (%), 2006
77
Figure 57: 3M Company, Value Chain Analysis 89
Figure 58:
Baxter International Inc., Value Chain Analysis 103
Figure 59: Flowchart
for Classification of Non-invasive Devices in Netherlands, 2007 126
Figure
60: Flowchart for Classification of Invasive Devices in Netherlands, 2007
127
Figure 61: Flowchart for Classification of Invasive Devices in
Netherlands, 2007 128
Figure 62: Flowchart for Classification of Invasive
Devices in Netherlands, 2007 129
Figure 63: Flowchart for Classification
of Invasive Devices in Netherlands, 2007 130
Figure 64: Flowchart for
Classification of Active Devices in Netherlands, 2007 131
Figure 65:
Flowchart for Classification of Active Devices in Netherlands, 2007 132
Figure 66: Flowchart for Classification of Devices except Non-invasive,
Invasive and Active Devices in Netherlands, 2007 133
Figure 67: Conformity
Assessment of Class-I Medical Devices in Netherlands, 2007 134
Figure 68:
Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007
135
Figure 69: Conformity Assessment of Class-IIb Medical Devices in
Netherlands, 2007 136
Figure 70: Conformity Assessment of Class-III
Medical Devices in Netherlands, 2007 137
Figure 71: Global Markets Direct
Methodology 140
View Cart
